FTC sues important pharmacy profit supervisors above insulin costs The company brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the checklist cost of daily life-preserving insulin medications. Since some electronic health startups funded through the peak from the investment increase https://andresfedjj.theideasblog.com/31120690/rumored-buzz-on-healthcare-news